AbbVie Inc/ US00287Y1091 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -CHF | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 280.09 bill.CHF | - | - |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 2.40 USD | -12.09% |
| EPS Diluted: | 2.39 USD | -12.13% |
| Revenues per Share: | 31.91 USD | 3.78% |
| Book Value per Share: | 1.91 USD | -67.62% |
| Cash Flow per Share: | 10.65 USD | -17.61% |
| Dividend per Share: | 6.29 USD | 5.01% |
| Total | in mill. | |
| Revenues: | 56,334.00 USD | 3.71% |
| Net Income: | 4,278.00 USD | -12.03% |
| Operating Cash Flow: | 18,806.00 USD | - |
| Cash and Cash Equivalents: | 5,524.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 80.63 | 74.04 |
| P/S Ratio: | 6.06 | 5.57 |
| P/BV ratio: | 101.55 | 93.25 |
| P/CF Ratio: | 18.17 | 16.68 |
| PEG: | -6.67 | -6.13 |
| Earnings Yield: | 1.24% | 1.35% |
| Dividend Yield: | 3.25% | 3.54% |
| Market Capitalization | ||
| Market Capitalization: | 280.09 bill. CHF | 284.75 bill. CHF |
| Free Float Market Cap.: | - CHF | - CHF |
| Market Cap. / Employee: | - CHF | - CHF |
| Shares Outstanding: | 1.77 bill. | |
Profitability
| Gross Profit Margin: | 69.99% |
| EBIT Margin: | 16.22% |
| Net Profit Margin: | 7.59% |
| Return on Equity: | 127.17% |
| Return on Assets: | 3.17% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.14% |
| Liquidity II / Quick Ratio: | 0.42% |
| Liquidity III / Current Ratio: | 0.66% |
| Debt / Equity Ratio: | 19.96% |
| Dynam. Debt / Equity Ratio: | 700.82% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2024 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
